CHF Solutions, Inc (CHFS)

[apollo1452]

Accelerated Sales Growth for Aquadex is Confirmed.

"CHFS has doubled the production staff that builds its next generation Aquadex SmartFlow consoles in response to increased demand from hospitals due to the coronavirus COVID-19."

"CHF Solutions has seen strong interest from additional hospitals & increased demand for this ultrafiltration therapy as the rate of affected patients continues to increase."

CHFS is on the doorstep of becoming profitable.

Aquadex Smart Flow machines $31,000 each, Filters $900 per one time use per patient.

"We anticipate a 70% plus margin on the disposable filter circuits."

"Regarding our cost of goods sold. We continue to see improvements in our gross margins resulting from the transition to in-house manufactured inventory. Our margins were about 51% for the quarter, 16 percentage points above last year's Q4 margins. For the year 2019, our gross margins were 51.7%, an increase of 25 percentage points over the prior year."